Literature DB >> 10487494

The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris.

T D Wang1, C M Lee, C C Wu, T M Lee, W J Chen, M F Chen, C S Liau, F C Sung, Y T Lee.   

Abstract

Large-scale clinical trials have shown that long-term treatment with lipid-lowering therapy results in a significant reduction in the occurrence of heart failure among patients with coronary artery disease without previous evidence of congestive heart failure, suggesting dyslipidemia may have an adverse effect on left ventricular performance. To examine whether dyslipidemia has a detrimental effect on left ventricular systolic function and whether this effect is dependent on the corresponding severity of coronary atherosclerosis, 114 consecutive patients with stable angina and a positive exercise thallium-201 myocardial perfusion single-photon emission computed tomography were studied. All patients underwent measurement of serum lipid profiles, right-sided heart catheterization, left ventriculography, and selective coronary arteriography. Mean serum levels of total cholesterol and triglycerides were 4.5 and 1.4 mmol/l, respectively. In univariate analysis, a significant positive correlation between serum high-density lipoprotein (HDL) cholesterol and left ventricular ejection fraction (LVEF) (r = 0.49, P<0.0001) was found. Patients in the lower tertile of serum HDL cholesterol had a significantly lower mean LVEF than those in the upper tertile (55.9+/-15.2 vs. 72.8+/-6.8%, P<0.0001). Stepwise multiple linear regression analysis revealed that LVEF significantly correlated with HDL cholesterol (P<0.0001), the Gensini score (P = 0.008), and diabetes mellitus (P = 0.08) (r = 0.55, P<0.0001). In subgroup analysis of patients with angiographically normal coronary arteries, serum HDL cholesterol was still significantly associated with LVEF. The present study demonstrated an independent association between low HDL cholesterol and subclinical left ventricular systolic dysfunction in Chinese patients with stable angina whose serum levels of total cholesterol and triglycerides were relatively low. Moreover, this correlation remained significant even in patients with normal coronary angiograms, suggesting HDL cholesterol might influence left ventricular systolic performance through extra-atherosclerotic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487494     DOI: 10.1016/s0021-9150(99)00108-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Cross-sectional relations of lipid concentrations to left ventricular structural attributes.

Authors:  Raghava S Velagaleti; Michael J Pencina; Ramachandran S Vasan; Emelia J Benjamin; Joseph M Massaro; Karol Pencina; Daniel Levy
Journal:  Am J Cardiol       Date:  2010-03-11       Impact factor: 2.778

2.  Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

3.  Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study.

Authors:  Zhi-Zhao Li; Xin Du; Xue-Yuan Guo; Ri-Bo Tang; Chao Jiang; Nian Liu; San-Shuai Chang; Rong-Hui Yu; De-Yong Long; Rong Bai; Cai-Hua Sang; Song-Nan Li; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Med Sci Monit       Date:  2018-06-09

Review 4.  Protective Effects of HDL Against Ischemia/Reperfusion Injury.

Authors:  Monica Gomaraschi; Laura Calabresi; Guido Franceschini
Journal:  Front Pharmacol       Date:  2016-01-25       Impact factor: 5.810

5.  Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes.

Authors:  Peter Godsk Jørgensen; Magnus Thorsten Jensen; Tor Biering-Sørensen; Rasmus Mogelvang; Søren Galatius; Thomas Fritz-Hansen; Peter Rossing; Tina Vilsbøll; Jan Skov Jensen
Journal:  Cardiovasc Diabetol       Date:  2016-09-22       Impact factor: 9.951

Review 6.  Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action.

Authors:  Manabu Nagao; Hideto Nakajima; Ryuji Toh; Ken-Ichi Hirata; Tatsuro Ishida
Journal:  J Atheroscler Thromb       Date:  2018-08-27       Impact factor: 4.928

7.  Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease.

Authors:  Henry Anselmo Mayala; Magesa Mafuru; Abdalah Mkangala; Mark Mayala; Pedro Pallangyo; Dickson Minja; Mohamed Janabi; Wang Zhao-Hui
Journal:  BMC Res Notes       Date:  2020-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.